Picture of Sumitomo Pharma logo

4506 — Sumitomo Pharma News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapValue Trap

Brief: Sumitomo Pharma Oncology Receives Orphan Drug Tag For Bone Cancer Drug

April 10 (Reuters) - Sumitomo Pharma Co Ltd  4506.T :
    * SUMITOMO PHARMA ONCOLOGY RECEIVES ORPHAN DRUG DESIGNATION
FOR
TP-1287, AN INVESTIGATIONAL ORAL CDK9 INHIBITOR FOR TREATMENT OF
EWING SARCOMA

Source text for Eikon:  ID:nPn2JgxDCa 
Further company coverage:  4506.T 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sumitomo Pharma

See all news